Genomic profiling and pathological assessment of malignant peripheral nerve sheath tumors
The findings emphasize the necessity of molecular testing for accurate diagnosis of MPNST, which can guide optimal therapeutic options and highlight the need for tailored treatment strategies considering the heterogeneity of pathological phenotypes and molecular features among patients.
Authors
- Jie Xu (ORCID: https://orcid.org/0000-0003-1957-8438)
- Qian Cui (ORCID: https://orcid.org/0009-0008-7577-2095)
- Fangping Xu (ORCID: https://orcid.org/0000-0002-8323-419X)
- Hongmei Wu (ORCID: https://orcid.org/0000-0002-1930-1183)
- Jian Liu (ORCID: https://orcid.org/0000-0002-1447-0973)
- Qingling Zhang (ORCID: https://orcid.org/0000-0001-6403-2595)
- Fen Zhang (ORCID: https://orcid.org/0000-0002-9978-2035)
Institutions
- Guangdong Academy of Medical Sciences (CN)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2025-05-14
- DOI
- https://doi.org/10.1007/s00432-025-06209-7
- Citations
- 1
- Primary Topic
- Neurofibromatosis and Schwannoma Cases
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- National Natural Science Foundation of China